This inventor holds 1 USPTO granted patent and 6 published patent applications and 1 EPO patent. Top assignee: Bayer Aktiengesellschaft. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Jeremie Xavier G. Mortier: Patent Activity in Pharmaceutical Innovation
Introduction
Jeremie Xavier G. Mortier is an inventor associated with Berlin, Germany. His patent activity includes work on phosphorus derivatives investigated as SOS1 inhibitors, a subject relevant to pharmaceutical research.
Latest Patents
The provided information lists one patent for Mortier: “Phosphorus Derivatives as SOS1 Inhibitors.” The invention covers phosphorus derivatives, methods for preparing them, useful intermediate compounds, pharmaceutical compositions, and combinations containing the compounds. It also describes their potential use in treating or preventing diseases, particularly hyperproliferative disorders associated with SOS1, either alone or alongside other active ingredients. The patent record reports 1 patent.
Career Highlights
Mortier’s listed company affiliations include Bayer Aktiengesellschaft and The Broad Institute, Inc. The available information does not specify his roles or the dates of these affiliations.
Collaborations
Keith Graham and Atanas Marinov Kamburov are identified as Mortier’s coworkers. The provided information does not detail their specific contributions to the patent.
Conclusion
Jeremie Xavier G. Mortier’s listed patent concerns phosphorus derivatives with potential applications in SOS1-related pharmaceutical research, reflecting an area of innovation focused on possible treatments for hyperproliferative disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile